See every side of every news story
Published loading...Updated

LINC00162 Silencing Enhances Sorafenib Sensitivity and Inhibits Thyroid Cancer Cells Progression through Modulation of MAPK Signaling and Apoptosis

Summary by researchsquare.com
Many studies have reported aberrant expression of the lncRNAs and indicated their role in cancer progression and drug resistance across various cancers. In this study, we aimed to evaluate the effect of the LINC00162 lncRNA in the chemosensitivity of thyroid cancer cells, both individually and...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

researchsquare.com broke the news in on Friday, April 4, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.